Agile Therapeutics Depreciation & Amortization 2011-2026 | AGRX

Annual Depreciation & Amortization Agile Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
102 K	1.28 M	2.06 M	105 K	18 K	23 K	23 K	19 K	18 K	12 K	12 K	23.7 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.06 M	12 K	308 K

Quarterly Depreciation & Amortization Agile Therapeutics

2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	26 K	-	-	-	26 K	-	1.26 M	1.06 M	527 K	-	1.55 M	1.03 M	513 K	-	20 K	8 K	4 K	-	14 K	10 K	5 K	-	18 K	12 K	6 K	-	16 K	11 K	5 K	-	14 K	9 K	4 K	-	14 K	10 K	5 K	-	7.73 K	5.04 K	2.59 K	-	9.15 K	6.16 K	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.55 M	2.59 K	200 K

Depreciation & Amortization of other stocks in the Drug manufacturers industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	311 K	-	7.5 %	$ 6.35 M	USA
Alimera Sciences ALIM	8.75 M	-	-	$ 142 M	USA
Aerie Pharmaceuticals AERI	6.4 M	-	-	$ 754 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.48 M	-	0.86 %	$ 117 M	USA
Athenex ATNX	4.47 M	-	-23.39 %	$ 1.76 M	USA
Eagle Pharmaceuticals EGRX	646 K	-	-39.89 %	$ 27.7 M	USA
Catalent CTLT	489 M	-	-	$ 11.5 B	USA
Avadel Pharmaceuticals plc AVDL	2.68 M	-	-	$ 2.06 B	France
DURECT Corporation DRRX	31 K	-	-	$ 50.1 M	USA
Organogenesis Holdings ORGO	13.6 M	$ 2.42	-0.82 %	$ 319 M	USA
Emergent BioSolutions EBS	125 M	$ 8.09	-1.46 %	$ 414 M	USA
Pacira BioSciences PCRX	78.8 M	$ 23.83	1.45 %	$ 1.1 B	USA
Endo International plc ENDP	306 M	-	-	$ 28.9 M	Irlanda
Perrigo Company plc PRGO	338 M	$ 9.56	-1.34 %	$ 1.32 B	USA
Cumberland Pharmaceuticals CPIX	4.9 M	$ 3.33	-0.75 %	$ 46.8 M	USA
Relmada Therapeutics RLMD	1.26 K	$ 6.55	-1.73 %	$ 259 M	USA
Rockwell Medical RMTI	1.44 M	$ 0.92	-11.46 %	$ 21.5 M	USA
SCYNEXIS SCYX	580 K	$ 0.83	-5.76 %	$ 41.4 M	USA
Bausch Health Companies BHC	1.26 B	$ 5.13	0.98 %	$ 1.87 B	Canada
Solid Biosciences SLDB	1.64 M	$ 7.87	8.85 %	$ 689 M	USA
PLx Pharma PLXP	116 K	-	-27.8 %	$ 2.56 M	USA
Tilray TLRY	35.7 M	$ 6.61	-4.76 %	$ 4.08 B	Canada
Evolus EOLS	7.51 M	$ 4.19	-4.12 %	$ 270 M	USA
Neoleukin Therapeutics NLTX	3.04 M	-	-	$ 193 M	Canada
TherapeuticsMD TXMD	922 K	$ 2.26	-1.27 %	$ 23.6 M	USA
OptiNose OPTN	402 K	-	-	$ 1.08 B	USA
PetIQ PETQ	44.5 M	-	1.64 %	$ 400 M	USA
Viatris VTRS	2.74 B	$ 13.4	-0.78 %	$ 16.1 B	USA
ProPhase Labs PRPH	4.72 M	-	-	$ 5.07 M	USA
Veru VERU	268 K	$ 2.21	-3.49 %	$ 298 M	USA
Radius Health RDUS	1.16 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	8.22 M	-	-4.76 %	$ 65.3 M	USA
Jupiter Wellness JUPW	429 K	-	-	$ 33.6 M	USA
Harrow Health HROW	1.32 M	$ 35.7	-1.79 %	$ 1.31 B	USA
China Pharma Holdings CPHI	2.62 M	$ 0.59	-7.21 %	$ 10.3 M	China
Sonoma Pharmaceuticals SNOA	138 K	$ 2.2	-3.51 %	$ 2.73 M	USA
cbdMD YCBD	452 K	$ 0.75	-6.52 %	$ 3.23 M	USA
Assertio Holdings ASRT	30 M	$ 19.65	5.82 %	$ 126 M	USA
Lannett Company LCI	34.3 M	-	1.15 %	$ 7.11 M	USA
Canopy Growth Corporation CGC	21.5 M	$ 0.94	-3.39 %	$ 101 M	Canada
Tricida TCDA	442 K	-	-	$ 3.25 M	USA
Zynerba Pharmaceuticals ZYNE	219 K	-	-	$ 55.5 M	USA